
AAA is a European leader in the production and commercialization of PET (Positron Emission Tomography) radiopharmaceuticals. PET is a state-of-the-art diagnostic technique that is today mainly used in clinical oncology, cardiology and neurology.
With 10 production facilities and R&D laboratories and more than 130 employees in 4 countries (France, Italy, Switzerland and Spain), AAA is a truly “private public company” with over 75 private and institutional shareholders.

